Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Operable Breast Neoplasms”

199 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 199 results

Not applicableStudy completedNCT00068328
What this trial is testing

Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer

Who this might be right for
Breast CancerPsychosocial Effects of Cancer and Its Treatment
Alliance for Clinical Trials in Oncology 1,706
Not applicableUnknownNCT03900299
What this trial is testing

Evaluating New Surgical Technique in Management of Female Patients With Operable Multifocal Breast Cancer

Who this might be right for
Breast Cancer
Alexandria University 114
Not applicableStudy completedNCT00814034
What this trial is testing

Coagulation Parameters in Postmenopausal Breast Cancer Patients Under Adjuvant Hormonal Therapy

Who this might be right for
Breast Cancer
Hellenic Breast Surgeons Society 306
Large-scale testing (Phase 3)Looking for participantsNCT05862064
What this trial is testing

A Multi-center, Randomized, Open-label, Phase III Study Comparing PD-1 Inhibitor Combined With Antivascular Therapy and Anthracycline/Taxane-based Adjuvant Chemotherapy Versus Anthracycline/Taxane-based Adjuvant Chemotherapy Alone in Patients With Operable Triple-negative Breast Cancer

Who this might be right for
TNBC - Triple-Negative Breast Cancer
Fudan University 606
Early research (Phase 1)Study completedNCT01133912
What this trial is testing

Preoperative Chemotherapy With Paclitaxel, Gemcitabine, and Lapatinib (Tykerb®) (PGT)

Who this might be right for
Breast Cancer
Jungsil Ro 13
Not applicableUnknownNCT01850628
What this trial is testing

NSABP Biospecimen Discovery Project

Who this might be right for
Breast Cancer
NSABP Foundation Inc 50
Large-scale testing (Phase 3)Study completedNCT00002707
What this trial is testing

Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed

Who this might be right for
Breast Cancer
NSABP Foundation Inc 2,411
Large-scale testing (Phase 3)UnknownNCT00002460
What this trial is testing

Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer

Who this might be right for
Breast Cancer
Cancer Research UK
Testing effectiveness (Phase 2)Study completedNCT02846428
What this trial is testing

To Evaluate the Efficacy and Safety of Capecitabine Prior to Surgery in Women With Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 182
Testing effectiveness (Phase 2)Study completedNCT01817452
What this trial is testing

A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Combination of Trastuzumab and Pertuzumab With or Without Concurrent Taxane Chemotherapy Given for Twelve Weeks in Patients With Operable HER2+/HR- Breast Cancer Within the ADAPT Protocol

Who this might be right for
Breast Cancer
West German Study Group 220
Large-scale testing (Phase 3)Study completedNCT01566721
What this trial is testing

A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer

Who this might be right for
Breast Neoplasms
Hoffmann-La Roche 2,577
Testing effectiveness (Phase 2)Ended earlyNCT00128362
What this trial is testing

Sentinel Node Biopsy and Axillary Sampling in Operable Breast Cancer

Who this might be right for
Cancer of the Breast
Tata Memorial Hospital 478
Not applicableEnded earlyNCT05447910
What this trial is testing

Analysis of Letrozole in Patients With Operable Hormone Receptor Positive, HER2 Negative Breast Cancer

Who this might be right for
Breast AdenocarcinomaInvasive Breast CarcinomaResectable Breast Carcinoma
Mayo Clinic 21
Testing effectiveness (Phase 2)Study completedNCT00530868
What this trial is testing

Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer

Who this might be right for
Breast CancerCancer of the BreastBreast Neoplasm
University of Alabama at Birmingham 75
Large-scale testing (Phase 3)Study completedNCT00513292
What this trial is testing

Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery

Who this might be right for
HER2/Neu PositiveStage IA Breast CancerStage IB Breast Cancer+2 more
National Cancer Institute (NCI) 280
Large-scale testing (Phase 3)Study completedNCT02003209
What this trial is testing

Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer

Who this might be right for
HER2-Positive Breast CarcinomaHormone Receptor-Positive Breast CarcinomaStage IB Breast Cancer AJCC v7+5 more
National Cancer Institute (NCI) 315
Not applicableStudy completedNCT00437853
What this trial is testing

Neoadjuvant Hormonal Treatment of Postmenopausal Women Who Have Operable Breast Cancer

Who this might be right for
Breast Cancer
Instituto Nacional de Cancerologia de Mexico 30
Large-scale testing (Phase 3)Study completedNCT05114720
What this trial is testing

Moxifloxacin in Adjuvant Treatment of Patients With Operable Breast Cancer

Who this might be right for
Breast Cancer
Sun Yat-sen University 559
Testing effectiveness (Phase 2)Study completedNCT03747042
What this trial is testing

Letrozole in Post-Menopausal Patients With Operable Hormone-Sensitive Breast Cancer

Who this might be right for
Breast Cancer Female
University of Texas Southwestern Medical Center 61
Testing effectiveness (Phase 2)Ended earlyNCT02720185
What this trial is testing

Window of Opportunity Trial of Dasatinib in Operable Triple Negative Breast Cancers With nEGFR

Who this might be right for
Breast NeoplasmsTriple Negative Breast Neoplasms
University of Wisconsin, Madison 5
Load More Results